EUVIMEDEUVIMED entdecken
Crossref

TTK inhibition activates STING signal and promotes anti-PD1 immunotherapy in breast cancer

Xiang Hu, Guangmei Li, Sisi Li, Qiwei Wang, Yuerong Wang, Peidong Zhang, Tianqiong Yang, Bo Yang, Luoting Yu, Zhihao Liu

Biochemical and Biophysical Research Communications · 2024

DOI: 10.1016/j.bbrc.2023.149388 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Xiang Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine and Laboratory of Emergency Medicine, State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biot…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite progress in the application of checkpoint immunotherapy against various tumors, attempts to utilize immune checkpoint blockade (ICB) agents in triple negative breast cancer (TNBC) have yielded limited clinical benefits. The low overall response rate of checkpoint immunotherapy in TNBC may be attributed to the immunosuppressive tumor microenvironment (TME). In this study, we investigated the role of mitogen-associated kinase TTK in reprogramming immune microenvironment in TNBC. Notably, TTK inhibition by BAY-1217389 induced DNA damage and the formation of micronuclei containing dsDNA in the cytosol, resulting in elicition of STING signal pathway and promoted antitumor immunity via the infiltration and activation of CD8+ T cells. Moreover, TTK inhibition also upregulated the expression of PD-L1, demonstrating a synergistic effect with anti-PD1 therapy in 4T1 tumor-bearing mice. Taken together, TTK inhibition facilitated anti-tumor immunity mediated by T cells and enhanced sensitivity to PD-1 blockade, providing a rationale for the combining TTK inhibitors with immune checkpoint blockade in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesTriple Negative Breast NeoplasmsAnimalsHumansMiceB7-H1 AntigenCell Cycle ProteinsCell Line, TumorImmune Checkpoint InhibitorsImmunotherapyProtein Serine-Threonine KinasesProtein-Tyrosine KinasesSignal TransductionTumor Microenvironment

Stichwörter der Autor:innen

ImmunotherapyPD-L1STINGTTKTumor immune microenvironment

Substanzen

B7-H1 AntigenCell Cycle ProteinsImmune Checkpoint InhibitorsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesTTK protein, human

Autor:innen und Institutionen

  • Department of Emergency Medicine and Laboratory of Emergency Medicine, State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, Sich…
  • Department of Breast Cancer, Chongqing University Cancer Hospital, Chongqing, 400030, China.
  • Yangzhou Center for Disease Control and Prevention, Yangzhou, 225007, Jiangsu, China.
  • Department of Oncology and Hematology, Western Theater Command Air Force Hospital of PLA, Chengdu, 610083, Sichuan, China.
  • Department of Pharmacy, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, 6091248, Sichuan, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Sichuan Province

Zitieren

APA

Hu, X., Li, G., Li, S., Wang, Q., Wang, Y., Zhang, P., Yang, T., Yang, B., Yu, L., & Liu, Z. (2024). TTK inhibition activates STING signal and promotes anti-PD1 immunotherapy in breast cancer. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.149388

Vancouver

Hu X, Li G, Li S, Wang Q, Wang Y, Zhang P, et al. TTK inhibition activates STING signal and promotes anti-PD1 immunotherapy in breast cancer. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2023.149388

BibTeX
@article{Hu2024,
  author = {Hu, Xiang and Li, Guangmei and Li, Sisi and Wang, Qiwei and Wang, Yuerong and Zhang, Peidong and Yang, Tianqiong and Yang, Bo and Yu, Luoting and Liu, Zhihao},
  title = {TTK inhibition activates STING signal and promotes anti-PD1 immunotherapy in breast cancer},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  doi = {10.1016/j.bbrc.2023.149388}
}
Kostenlos starten →